Cleveland JL - Search Results

1

Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.

Eischen CM, Weber JD, Roussel MF, Sherr CJ, Cleveland JL. Eischen CM, et al. Among authors: cleveland jl. Genes Dev. 1999 Oct 15;13(20):2658-69. doi: 10.1101/gad.13.20.2658. Genes Dev. 1999. PMID: 10541552 Free PMC article.

2

Loss of Bax alters tumor spectrum and tumor numbers in ARF-deficient mice.

Eischen CM, Rehg JE, Korsmeyer SJ, Cleveland JL. Eischen CM, et al. Among authors: cleveland jl. Cancer Res. 2002 Apr 1;62(7):2184-91. Cancer Res. 2002. PMID: 11929842

3

Arf tumor suppressor promoter monitors latent oncogenic signals in vivo.

Zindy F, Williams RT, Baudino TA, Rehg JE, Skapek SX, Cleveland JL, Roussel MF, Sherr CJ. Zindy F, et al. Among authors: cleveland jl. Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15930-5. doi: 10.1073/pnas.2536808100. Epub 2003 Dec 9. Proc Natl Acad Sci U S A. 2003. PMID: 14665695 Free PMC article.

4

Antagonism of Myc functions by Arf.

Cleveland JL, Sherr CJ. Cleveland JL, et al. Cancer Cell. 2004 Oct;6(4):309-11. doi: 10.1016/j.ccr.2004.09.020. Cancer Cell. 2004. PMID: 15488753 Free article.

5

Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2f1 loss.

Baudino TA, Maclean KH, Brennan J, Parganas E, Yang C, Aslanian A, Lees JA, Sherr CJ, Roussel MF, Cleveland JL. Baudino TA, et al. Among authors: cleveland jl. Mol Cell. 2003 Apr;11(4):905-14. doi: 10.1016/s1097-2765(03)00102-3. Mol Cell. 2003. PMID: 12718877 Free article.

6

Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization.

Zindy F, Eischen CM, Randle DH, Kamijo T, Cleveland JL, Sherr CJ, Roussel MF. Zindy F, et al. Among authors: cleveland jl. Genes Dev. 1998 Aug 1;12(15):2424-33. doi: 10.1101/gad.12.15.2424. Genes Dev. 1998. PMID: 9694806 Free PMC article.

7

Disruption of the ARF transcriptional activator DMP1 facilitates cell immortalization, Ras transformation, and tumorigenesis.

Inoue K, Wen R, Rehg JE, Adachi M, Cleveland JL, Roussel MF, Sherr CJ. Inoue K, et al. Among authors: cleveland jl. Genes Dev. 2000 Jul 15;14(14):1797-809. Genes Dev. 2000. PMID: 10898794 Free PMC article.

8

Apoptosis triggered by Myc-induced suppression of Bcl-X(L) or Bcl-2 is bypassed during lymphomagenesis.

Eischen CM, Woo D, Roussel MF, Cleveland JL. Eischen CM, et al. Among authors: cleveland jl. Mol Cell Biol. 2001 Aug;21(15):5063-70. doi: 10.1128/MCB.21.15.5063-5070.2001. Mol Cell Biol. 2001. PMID: 11438662 Free PMC article.

9

Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis.

Eischen CM, Roussel MF, Korsmeyer SJ, Cleveland JL. Eischen CM, et al. Among authors: cleveland jl. Mol Cell Biol. 2001 Nov;21(22):7653-62. doi: 10.1128/MCB.21.22.7653-7662.2001. Mol Cell Biol. 2001. PMID: 11604501 Free PMC article.

10

Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.

Eischen CM, Packham G, Nip J, Fee BE, Hiebert SW, Zambetti GP, Cleveland JL. Eischen CM, et al. Among authors: cleveland jl. Oncogene. 2001 Oct 25;20(48):6983-93. doi: 10.1038/sj.onc.1204892. Oncogene. 2001. PMID: 11704823

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

282 results

Search Page